T. Rowe Price Associates’s Actinium Pharmaceuticals ATNM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-12,785
Closed -$21K 3065
2025
Q1
$21K Buy
+12,785
New +$21K ﹤0.01% 3001